Agronomics invests a further US$500,000 in VitroLabs

Agronomics plc (LON:ANIC), the leading London-listed investor in alternative proteins with a focus on cellular agriculture and cultivated meat, has announced it has today invested a further US$ 500,000 in VitroLabs Inc, a cellular agriculture company creating slaughter-free, environmentally friendly cultivated leather.

VitroLabs has made substantial technical and commercial progress over the past year, reaching significant milestones around production cost reduction, consistent leather quality, increased platform production capacity and process efficiency, as well as securing key partnerships.

The Subscription is in the form of a convertible loan note, which will convert at VitroLabs’ next funding round. Agronomics had previously invested US$ 2,500,000 in total in the form of two SAFEs: the first in October 2019 and the second in February 2020. The approximate equity ownership upon conversion at the valuation cap of the CLN and the SAFEs for Agronomics will be approximately 5.25 per cent. The Subscription will be paid using cash from the Company’s own resources. This follow-on investment does not result in a change of the carrying value of the Company’s existing investments in VitroLabs.

Commenting on the investment, Richard Reed, Chairman of Agronomics, noted:

“We are glad to continue to support Ingvar and his team as VitroLabs moves from being research and development centric, towards commercialisation. 

Just as consumers are paying more attention to the environmental footprint of their food consumption, the same goes for fashion.  The major global fashion houses are acutely aware of this shift, but until now have had no credible alternatives that perform at the level required to replace conventionally farmed leather.”

Ingvar Helgason, Co-founder and CEO of VitroLabs, added:

“At VitroLabs, our mission is to produce authentic materials without compromise. By harnessing science and nature, our cultivated leather has the same performance and versatility as traditional leather, but dramatically reduces the environmental footprint and eliminates animal welfare issues associated with conventional leather production.

We are thrilled to have the continued support of Agronomics as we scale our operations and move toward our common goal of improving animal, human and planetary health through sustainable solutions.”

The CLN is unsecured and for a term of 2 years with an interest rate of 6 per cent per annum.  The CLN converts at the lower of a valuation cap of US$ 75m or a 10% discount to the next financing and into the same class of shares issued at the Conversion Event, which is anticipated to be VitroLabs’ Series A financing.

Click to view all articles for the EPIC: ,
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn

    More articles like this

    Fintel plc

    Fintel Plc appoint Phil Smith as Non-Executive Director

    Fintel plc (LON: FNTL), the leading provider of Fintech and support services to the UK retail financial services sector, has announced the appointment of Phil Smith as Independent Non-Executive Director with immediate effect. Following a robust process led

    Pendragon plc

    Pendragon underlying Profit before Tax of £18.7m, up 73.1%

    Pendragon plc (LON:PDG) has announced its interim management statement. This Interim Management Statement covers the period from 1 January 2022 to 31 March 2022.  Unless otherwise stated, figures quoted in this statement are for the three

    SpaceandPeople returns to profit

    SpaceandPeople plc (LON:SAL) secures, sells, and manages flexible space for brand experiences, short term promotions and retailing in high footfall venues for its customers, including in shopping centres and travel hubs. The Group has issued full

    SpaceandPeople back into profit and positive earnings per share

    SpaceandPeople plc (LON:SAL) the retail, promotional and brand experience specialist, has announced its final results for the year ended 31 December 2021.   Financial Highlights ·       Revenue of £4.0 million (2020: £2.8 million and 2019: £7.7 million) ·       Operating profit of

    tinyBuild plc

    tinyBuild acquihires development studio Demagic Games

    tinyBuild plc (LON:TBLD), a premium video games publisher and developer with global operations, has announced the acquihire of Demagic Games, a development studio with 23 staff[1] currently based in Ukraine and Russia. The Company has been working

    Vertu Motors Plc

    Vertu Motors share buyback programme update

    Vertu Motors plc (LON: VTU) has announced that on 07 April 2022, it purchased 201,999 ordinary shares of 10p each in the Company on the London Stock Exchange, pursuant to the share buyback programme that was announced on 2nd March 2022 as

    Oncimmune Holdings report two further ImmunoINSIGHTS contracts signed

    Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, today announced the signing of two new ImmunoINSIGHTS commercial contracts. The first contract is with an US-based clinical-stage biopharmaceutical company which is developing first-in-class cellular immunotherapies for cancer

    Lookers Plc

    Lookers shares to trade in excess of 150p says Zeus

    Lookers plc (LON:LOOK) has announced FY21 results that show record underlying PBT of £90.7m, 5.3% above our forecast of £86.2m. The outlook is suitably cautious given current supply constraints and likely impact of inflation on future